November 5, 2007 - Dilon Technologies will highlight Breast-Specific Gamma Imaging (BSGI), a molecular imaging technique reportedly proven to be an effective tool in the early detection of breast cancer and in the differentiation of malignant and benign tumors.

The Dilon 6800 portable gamma camera has been optimized for breast imaging, and is said to overcome the limitations of standard gamma cameras in breast cancer diagnostics. Dilon’s high- resolution compact detector captures vital information by viewing metabolic activity via radiopharmaceutical uptake. It can detect cancers as small as 3 millimeters, see lesions independent of tissue density and is capable of providing all the same views as mammography.

For more information: www.dilon.com


Additional Content

News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Radiation Therapy

January 19, 2024 — Treating tumors is a global health issue. In radiotherapy, radiation is used to destroy tumor cells ...

Time January 19, 2024
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
News | Radiology Imaging

August 24, 2023 — Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with ...

Time August 24, 2023
arrow
Subscribe Now